T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Archrock
AROC
$5.87B
| $303M | 0.08% |
11,001,363
+2,578,542
| +31% | +$75.5M |
|
302
HCA Healthcare
HCA
$88.8B
| $302M | 0.08% |
7,073,547
-296,802
| -4% | -$11.6M |
|
303
Lazard
LAZ
$4.32B
| $302M | 0.08% |
8,390,219
+645,800
| +8% | +$22.9M |
|
304
Enovis
ENOV
$1.43B
| $302M | 0.08% |
3,101,272
-149,706
| -5% | -$13.8M |
|
|
GM.PRB
305
DELISTED
GENERAL MTRS CO JR PFD CONV SER B (DE)
GM.PRB
| $301M | 0.08% |
5,987,245
-237,050
| -4% | -$11.8M |
|
306
Lincoln National
LNC
$8.58B
| $299M | 0.07% |
7,111,433
-9,500
| -0.1% | -$401K |
|
|
POT
307
DELISTED
Potash Corp Of Saskatchewan
POT
| $298M | 0.07% |
9,533,004
-307,261
| -3% | -$10.2M |
|
308
Humana
HUM
$46.2B
| $297M | 0.07% |
3,187,070
+1,786,013
| +127% | +$164M |
|
|
CB
309
DELISTED
CHUBB CORPORATION
CB
| $296M | 0.07% |
3,320,714
-15,575
| -0.5% | -$1.35M |
|
|
FNGN
310
DELISTED
Financial Engines, Inc.
FNGN
| $292M | 0.07% |
4,917,069
-45,970
| -0.9% | -$2.45M |
|
311
PVH
PVH
$3.77B
| $291M | 0.07% |
2,451,201
-422,054
| -15% | -$54.2M |
|
312
Kilroy Realty
KRC
$4.3B
| $289M | 0.07% |
5,777,113
+19,817
| +0.3% | +$1.02M |
|
|
AEGR
313
DELISTED
Aegerion Pharmaceuticals
AEGR
| $289M | 0.07% |
3,366,300
-193,100
| -5% | -$16.4M |
|
314
FMC
FMC
$1.25B
| $287M | 0.07% |
4,615,876
+1,125,186
| +32% | +$64.6M |
|
|
SCHW
315
Charles Schwab
SCHW
$190B
| $287M | 0.07% |
13,562,017
-3,261,310
| -19% | -$70.9M |
|
|
ATML
316
DELISTED
ATMEL CORP
ATML
| $286M | 0.07% |
38,419,200
-15,452,750
| -29% | -$117M |
|
317
Chord Energy
CHRD
$7.32B
| $285M | 0.07% |
5,800,380
+209,300
| +4% | +$8.79M |
|
318
Allegiant Air
ALGT
$2.41B
| $284M | 0.07% |
2,698,129
+77,330
| +3% | +$7.64M |
|
|
YOKU
319
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $284M | 0.07% |
10,353,623
-1,476,858
| -12% | -$33.8M |
|
320
Becton Dickinson
BDX
$49.6B
| $283M | 0.07% |
2,896,454
+1,949,281
| +206% | +$191M |
|
|
ABCO
321
DELISTED
Advisory Board Co
ABCO
| $282M | 0.07% |
4,737,084
-16,800
| -0.4% | -$965K |
|
|
BRCM
322
DELISTED
BROADCOM CORP CL-A
BRCM
| $281M | 0.07% |
10,819,856
-14,160,624
| -57% | -$400M |
|
323
MGM Resorts International
MGM
$11.1B
| $281M | 0.07% |
13,760,389
+1,013,320
| +8% | +$17.6M |
|
324
Pediatrix Medical
MD
$2.13B
| $280M | 0.07% |
5,572,600
-33,000
| -0.6% | -$1.61M |
|
325
3D Systems Corp
DDD
$598M
| $280M | 0.07% |
5,179,048
-1,884,186
| -27% | -$93.2M |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.